Veena Rao
Direktor/Vorstandsmitglied bei PREDICTIVE ONCOLOGY INC.
Vermögen: 15 134 $ am 30.04.2024
Profil
Veena Rao is an Independent Director at Predictive Oncology, Inc. and the President & Chief Business Officer at Portal Instruments, Inc. She previously worked as a Director at Thermalin, Inc. and as the Chief Commercial Officer at Beta Bionics, Inc. Dr. Rao holds a doctorate degree from Stanford University, an undergraduate degree from the University of Minnesota, and an MBA from the University of Virginia Darden School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PREDICTIVE ONCOLOGY INC
0,22% | 05.04.2024 | 9 117 ( 0,22% ) | 15 134 $ | 30.04.2024 |
Aktive Positionen von Veena Rao
| Unternehmen | Position | Beginn |
|---|---|---|
| PREDICTIVE ONCOLOGY INC. | Direktor/Vorstandsmitglied | 02.05.2023 |
Portal Instruments, Inc.
 Portal Instruments, Inc. Medical SpecialtiesHealth Technology Portal Instruments, Inc. operates as a medical device company that focuses on drug delivery systems. It manufactures jet injectors that deliver drugs through the skin without a needle at specific depths and volumes. The firm engages in developing and commercializing a needle-free platform technology to transform the delivery of medicines and improve the patient experience. The company was founded by Patrick A. Anquetil and Ian W. Hunter in 2012 and is headquartered in Cambridge, MA. | Präsident | 01.12.2022 |
Ehemalige bekannte Positionen von Veena Rao
| Unternehmen | Position | Ende |
|---|---|---|
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.08.2022 |
Thermalin, Inc.
 Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Direktor/Vorstandsmitglied | - |
Ausbildung von Veena Rao
| University of Minnesota | Undergraduate Degree |
| Stanford University | Doctorate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PREDICTIVE ONCOLOGY INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Portal Instruments, Inc.
Portal Instruments, Inc. Medical SpecialtiesHealth Technology Portal Instruments, Inc. operates as a medical device company that focuses on drug delivery systems. It manufactures jet injectors that deliver drugs through the skin without a needle at specific depths and volumes. The firm engages in developing and commercializing a needle-free platform technology to transform the delivery of medicines and improve the patient experience. The company was founded by Patrick A. Anquetil and Ian W. Hunter in 2012 and is headquartered in Cambridge, MA. | Health Technology |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Health Technology |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Health Technology |
